Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release May 18 2026

May 17, 2026 at 11:26 PM EDT · Issued by Glenmark Pharmaceuticals Limited

Filed with NSE · May 17, 2026 at 11:26 PM EDT · 3 pages · English

On 6ix: 6ix.com/news/press-release-may-18-2026-5

Release

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 18, 2026, titled "Glenmark Pharmaceuticals Inc., USA Launches Vancomycin Hydrochloride for Injection USP, 500mg/vial and 1 g/vial".

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Press Release Apr 09 2026Apr 9
Press Release Apr 01 2026Apr 1
Glenmark Pharmaceuticals Announces Strategic Shift to Direct Commercialization and Distribution of RYALTRIS® in the U.S., Significantly Expanding Its Innovative PortfolioApr 1
Press Release Mar 21 2026Mar 21
Press Release Mar 19 2026Mar 19

Later from Glenmark Pharmaceuticals

Press Release May 20 2026May 20
Press Release May 29 2026May 29
Press Release Jun 05 2026Jun 4
Glenmark Pharmaceuticals Limited Press Release Jun 11 2026Jun 11
Glenmark Pharmaceuticals Limited Press Release Jun 17 2026Jun 16

All Glenmark Pharmaceuticals news releases

Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.

Follow Glenmark Pharmaceuticals